Department of Pharmacy and Life Science, University of South China, Hengyang, 421001, People's Republic of China.
J Assist Reprod Genet. 2012 Jul;29(7):603-7. doi: 10.1007/s10815-012-9762-6. Epub 2012 May 3.
The purpose of this study was to determine the incidence of premature luteinization in patients with polycystic ovary syndrome and compared the main determinants of success in in-vitro fertilization in PCOS patients with and without premature luteinization.
Retrospective analysis of 180 PCOS women of Chinese Han origin with infertility who underwent controlled ovarian hyperstimulation (COH) with an exogenous gonadotropin/GnRH antagonist protocol. Hormone levels on the hCG day and IVF outcomes were assessed.
The incidence of premature luteinization was 23.3 %. Compared with PCOS patients without premature luteinization, PCOS patients with premature luteinization(PL) had a higher number of oocytes retrieved (18.20 ± 6.6 vs 15.08 ± 7.3, p = 0.037) and a higher fertilization rate (72.9 ± 1.9 vs63.1 ± 2.3, p = 0.033), but clinical pregnancy rates were no statistical significance (53.3 vs 56.0, p = 0.836). Though the implantation rate was higher in no premature luteinization patients, but the difference was not statistically significant (37.7 vs 30.3, p = 0.115).
The PCOS patients with premature luteinization had a higher fertilization rate and high number of oocytes retrieved, and the similar implantation rate and clinical PRs as PCOS patients without premature luteinization.
本研究旨在确定多囊卵巢综合征(PCOS)患者中黄体过早出现的发生率,并比较黄体过早出现与无黄体过早出现的 PCOS 患者体外受精(IVF)成功的主要决定因素。
回顾性分析了 180 例患有不孕症的汉族 PCOS 女性,她们接受了外源性促性腺激素/GnRH 拮抗剂方案的控制性卵巢超刺激(COH)。评估了 hCG 日的激素水平和 IVF 结局。
黄体过早出现的发生率为 23.3%。与无黄体过早出现的 PCOS 患者相比,黄体过早出现(PL)的 PCOS 患者获得的卵母细胞数更多(18.20±6.6 对 15.08±7.3,p=0.037),受精率更高(72.9±1.9 对 63.1±2.3,p=0.033),但临床妊娠率无统计学意义(53.3 对 56.0,p=0.836)。尽管黄体过早出现的患者着床率较高,但差异无统计学意义(37.7 对 30.3,p=0.115)。
黄体过早出现的 PCOS 患者受精率较高,获得的卵母细胞数较多,与无黄体过早出现的 PCOS 患者相比,着床率和临床妊娠率相似。